PaulChristopherMcGovernMD

Physician

Dr. McGovern is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
51 N 39th St
3910 Building, 2nd Floor
Philadelphia, PA 19104
Phone+1 215-662-9990

Fax+1 215-243-4658

University of Pennsylvania Health SystemFellowship, Infectious Disease, 1999 - 2001
University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
Northwestern University The Feinberg School of MedicineClass of 1996

PubMed

9 citations
The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence ...
Thomas L Hunt, Evan Tzanis, Stephen Bai, Amy Manley, Surya Chitra
European Journal of Drug Metabolism and Pharmacokinetics. 2021-01-01
70 citations
All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials
Paul C. McGovern, Michele Wible, Ahmed El-Tahtawy, Pinaki Biswas, R. Daniel Meyer
International Journal of Antimicrobial Agents. 2013-05-01
55 citations
Risk Factors for Postcraniotomy Surgical Site Infection after 1,3-Bis (2-Chloroethyl)-1-Nitrosourea (Gliadel) Wafer Placement
Paul C. McGovern, Ebbing Lautenbach, Patrick J. Brennan, Robert A. Lustig, Neil O. Fishman
Clinical Infectious Diseases. 2003-03-15

FDA Accepts New Antibiotic Combo for Priority Review for Complicated UTIAugust 16th, 2023
FDA OKs Priority Review for Antibiotic Combo for Complicated UTIsAugust 23rd, 2023
Novel Antibiotic Combo Bests Meropenem for Complicated UTIsFebruary 15th, 2024
Join now to see all